Mengxin Chen

Mengxin Chen is a Senior Medical Writer at CStone Pharmaceuticals since September 2018, with previous experience as a Medical Writer at Pfizer from July 2016 to September 2018 and in Regulatory CMC at Novartis from June 2015 to July 2016. Prior to these roles, Mengxin worked as a Scientist at WuXi AppTec from March 2012 to March 2015, focusing on designing and authoring stability protocols. Mengxin holds a Master's degree in Pharmaceutical Analysis and Quality Control from King's College London and Bachelor's degrees in Herbal Science from London Metropolitan University and Pharmaceutical Sciences from Shanghai University of Traditional Chinese Medicine.